Relation of diabetes to coronary artery ectasia: A meta-analysis study

HUANG, Qiao-Juan; CHEN, Meng-Hua; LİU, Jun; LI, Jian-Jun

Relation of diabetes to coronary artery ectasia: A meta-analysis study

Qiao-Juan HUANG, (Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China)

Jun LİU, (Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China)

Meng-Hua CHEN, (Department of Cardiology, Institute of Cardiovascular Diseases, the First Affiliated Hospital, Guangxi Medical University; Nanning, Guangxi PR, China)

Jian-Jun LI (Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China)

Anadolu Kardiyoloji Dergisi

4 0

Yıl: 2014 Cilt: 14 Sayı: 4 Sayfa Aralığı: 322 - 327 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Relation of diabetes to coronary artery ectasia: A meta-analysis study

Öz:

Objective: Previous studies have shown a significant negative association between diabetes and abdominal aortic aneurysm. However, the relation of diabetes to coronary artery ectasia (CAE) has not well established. The aim of the current study was to conduct a systemic review for evaluating the relationship between diabetes and CAE. Methods: A systemic search of electronic databases (PUBMED, EMBASE, OVID, WEB OF SCIENCE, THE COCHRANCE LIBRARY) from 1970 to March 2013 was performed. Additionally, checking reference lists from identified articles, reviews, and the abstracts presented at related sci- entific meetings were also carried out. All case-control studies investigating appropriate prevalence data were included. Results: Among 328 articles, 10 case-control studies were finally identified. The prevalence of diabetes in studied patients with CAE was 8% to 33%, while in those without CAE was ranged from 13.5% to 35%. Pooled analysis showed a reduced rate of diabetes amongst patients with CAE compared to those without (OR 0.65, 0.54-0.77, p<0.0001). Conclusion: Our findings suggested that diabetes might play a protective role for the development of CAE, indicating that further study is needed to evaluate the association diabetes and CAE including underlying mechanisms and future medical interventional strategies.

Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Swaye PS, Fisher LD, Litwin P Vignola PA, Judkins MP Kemp HG, et al. Aneurysmal coronary artery disease. Circulation 1983; 67: 134-8. [CrossRef]
2. Li JJ, Li Z, Li J. Is any link between inflammation and coronary artery ectasia? Med Hypotheses 2007; 69: 678-83. [CrossRef]
3. Diaz-Zamudio M, Bacilio-Perez U, Herrera-Zarza MC, Meave- Gonzalez A, Alexanderson-Rosas E, Zambrana-Balta GF, et al. Coronary artery aneurysms and ectasia: role of coronary CT angi- ography. Radiographics 2009; 29: 1939-54. [CrossRef]
4. Li JJ, Nie SP Qian XW, Zeng HS, Zhang CY. Chronic inflammatory status in patients with coronary artery ectasia. Cytokine 2009; 46: 61-4. [CrossRef]
5. Zhuo L, Zou G, Li W, Lu J, Ren W. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus. Eur J Med Res 2013; 18: 4. [CrossRef]
6. Wang YN, Yan RY. Clinical analysis of 279 cases of coronary artery ectasia. J Tianjin Med Uni 2013; 19: 134-6.
7. Shantikumar S, Ajjan R, Porter KE, Scott DJ. Diabetes and the abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2010; 39: 200-7. [CrossRef]
8. Stajduhar KC, Laird JR, Rogan KM, Wortham DC. Coronary arterial ectasia: increased prevalence in patients with abdominal aortic aneurysm as compared to occlusive atherosclerotic peripheral vascular disease. Am Heart J 1993; 125: 86-92. [CrossRef]
9. Kishi K, Ito S, Hiasa Y. Risk factors and incidence of coronary artery lesions in patients with abdominal aortic aneurysms. Intern Med 1997; 36: 384-8. [CrossRef]
10. Androulakis AE, Andrikopoulos GK, Kartalis AN, Stougiannos PN, Katsaros AA, Syrogiannidis DN, et al. Relation of coronary artery ectasia to diabetes mellitus. Am J Cardiol 2004; 93: 1165-7. [CrossRef]
11. Baman TS, Cole JH, Devireddy CM, Sperling LS. Risk factors and outcomes in patients with coronary artery aneurysms. Am J Cardiol 2004; 93: 1549-51. [CrossRef]
12. Pinar Bermudez E, Lopez Palop R, Lozano Martinez-Luengas I, Cortes Sanchez R, Carrillo Saez P Rodriguez Carreras R, et al. Coronary ectasia: prevalence, and clinical and angiographic char- acteristics. Rev Esp Cardiol 2003; 56: 473-9. [CrossRef]
13. Sağlam M, Karakaya O, Barutçu I, Esen AM, Türkmen M, Kargın R, et al. Identifying cardiovascular risk factors in a patient population with coronary artery ectasia. Angiology 2008; 58: 698-703. [CrossRef]
14. Boles U, Zhao Y, David S, Eriksson P Henein MY. Pure coronary ectasia differs from atherosclerosis: morphological and risk fac- tors analysis. Int J Cardiol 2011; 155: 321-3. [CrossRef]
15. Yao YA, Zhang SY, Wu W, Chen LF. The clinical manifestations and angiographic characteristics of coronary artery ectasia. Zhonghua Nei Ke Za Zhi 2010; 49: 389-91.
16. Güneş Y, Boztosun B, Yıldız A, Metin Esen A, Sağlam M, Bulut M, et al. Clinical profile and outcome of coronary artery ectasia. Heart 2006; 92: 1159-60. [CrossRef]
17. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-12. [CrossRef]
18. Demopoulos VP Olympios CD, Fakiolas CN, Pissimissis EG, Economides NM, Adamopoulou E, et al. The natural history of aneurysmal coronary artery disease. Heart 1997; 78: 136-41.
19. Waly HM, Elayda MA, Lee VV, el-Said G, Reul GJ, Hall RJ. Coronary artery ectasia in Egyptian patients with coronary artery disease. Tex Heart Inst J 1997; 24: 349-52.
20. Şen N, Özcan F, Uygur B, Aksu T, Akpınar I, Çay S, et al. Elevated serum uric acid levels in patients with isolated coronary artery ectasia. Türk Kardiyol Dern Ars 2009; 37: 467-72.
21. Li JJ. Inflammation in coronary artery diseases. Chin Med J (Engl) 2011; 124: 3568-75.
22. Adiloğlu AK, Öcal A, Taş T, Önal S, Kapan S, Arıdoğan B. Increased expression of CD11a and CD45 on leukocytes and decreased serum TNF-alpha levels in patients with isolated coronary artery ectasia. Clin Lab 2011; 57: 703-9.
23. Turhan H, Erbay AR, Yaşar AS, Aksoy Y, Biçer A, Yetkin G, et al. Plasma soluble adhesion molecules; intercellular adhesion mole- cule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia. Coron Artery Dis 2005; 16: 45-50. [CrossRef]
24. Antoniadis AP Chatzizisis YS, Giannoglou GD. Pathogenetic mecha- nisms of coronary ectasia. Int J Cardiol 2008; 130: 335-43. [CrossRef]
25. Aboeata AS, Sontineni SP Alla VM, Esterbrooks DJ. Coronary artery ectasia: current concepts and interventions. Front Biosci (Elite Ed) 2012; 4: 300-10. [CrossRef]
26. Chatzizisis YS, Coşkun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cel- lular, and vascular behavior. J Am Coll Cardiol 2007; 49: 2379-93. [CrossRef]
27. Sukhova GK, Wang B, Libby P Pan JH, Zhang Y, Grubb A, et al. Cystatin C deficiency increases elastic lamina degradation and aor- tic dilatation in apolipoprotein E-null mice. Circ Res 2005; 96: 368-75. [CrossRef]
28. Prescott MF, Sawyer WK, Von Linden-Reed J, Jeune M, Chou M, Caplan SL, et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor- deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann N Y Acad Sci 1999; 878: 179-90. [CrossRef]
29. Blanchard JF, Armenian HK, Friesen PP Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000; 151: 575-83. [CrossRef]
30. Le MT, Jamrozik K, Davis TM, Norman PE. Negative association between infra-renal aortic diameter and glycaemia: the Health in Men Study. Eur J Vasc Endovasc Surg 2007; 33: 599-604. [CrossRef]
31. Kolset SO, Reinholt FP Jenssen T. Diabetic nephropathy and extra- cellular matrix. J Histochem Cytochem 2012; 60: 976-86. [CrossRef]
32. Singh R, Barden A, Mori T, Beilin L. Advanced glycation end-prod- ucts: a review. Diabetologia 2001; 44: 129-46. [CrossRef]
33. Howard EW, Benton R, Ahern-Moore J, Tomasek JJ. Cellular con- traction of collagen lattices is inhibited by nonenzymatic glycation. Exp Cell Res 1996; 228: 132-7. [CrossRef]
34. Hammes HP Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, et al. Modification of vitronectin by advanced glycation alters func- tional properties in vitro and in the diabetic retina. Lab Invest 1996; 75: 325-38.
35. Kass DA, Shapiro EP Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, et al. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001; 104: 1464-70. [CrossRef]
36. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glyca- tion end products: sparking the development of diabetic vascular injury. Circulation 2006; 114: 597-605. [CrossRef]
37. Zhang L, Pang S, Deng B, Qian L, Chen J, Zou J, et al. High glucose induces renal mesangial cell proliferation and fibronectin expres- sion through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. Int J Biochem Cell Biol 2012; 44: 629-38. [CrossRef]
38. Vavuranakis M, Stefanadis C, Toutouzas K, Pitsavos C, Spanos V, Toutouzas P Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultra- sound study. Eur Heart J 1997; 18: 1090-4. [CrossRef]
39. Kornowski R, Mintz GS, Lansky AJ, Hong MK, Kent KM, Pichard AD, et al. Paradoxic decreases in atherosclerotic plaque mass in insulin-treated diabetic patients. Am J Cardiol 1998; 81: 1298-304. [CrossRef]
40. Dua MM, Miyama N, Azuma J, Schultz GM, Sho M, Morser J, et al. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery 2010; 148: 429-35. [CrossRef]
41. Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, et al. Hyperglycemia limits experimental aortic aneurysm progression. J Vasc Surg 2010; 52: 975-83. [CrossRef]
42. Doğan A, Tüzün N, Türker Y, Akçay S, Kaya S, Özaydın M. Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: their relationship to severity of coronary artery ectasia. Coron Artery Dis 2008; 19: 559-63. [CrossRef]
43. Peng Q, Zhou TF, Chen CH, Hua YM, Liu HM, Hong H, et al. Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coro- nary artery lesion in patients with Kawasaki disease. Zhonghua Er Ke Za Zhi 2005; 43: 676-80.
44. Sakata K, Hamaoka K, Ozawa S, Niboshi A, Yahata T, Fujii M, et al. Matrix metalloproteinase-9 in vascular lesions and endothelial regulation in Kawasaki disease. Circ J 2010; 74: 1670-5. [CrossRef]
45. Khan JA, Abdul Rahman MN, Mazari FA, Shahin Y, Smith G, Madden L, et al. Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneu- rysms. Ann Vasc Surg 2012; 26: 322-9. [CrossRef]
46. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006; 91: 847-51. [CrossRef]
47. Dahi S, Karliner JS, Sarkar R, Lovett DH. Transgenic expression of matrix metalloproteinase-2 induces coronary artery ectasia. Int J Exp Pathol 2011; 92: 50-6. [CrossRef]
48. Poteryaeva ON, Russkich GS, Panin LE. Analysis of serum activities of matrix metalloproteinases and alpha1-proteinase inhibitor in patients with type 2 diabetes mellitus. Bull Exp Biol Med 2012; 152: 578-9. [CrossRef]
49. Zayani Y, Allal-Elasmi M, Jacob MP Zidi W, Ftouhi B, Feki M, et al. Abnormal circulating levels of matrix metalloproteinases and their inhibitors in diabetes mellitus. Clin Lab 2012; 58: 779-85.
50. Kuzuya M, Asai T, Kanda S, Maeda K, Cheng XW, Iguchi A. Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice. Diabetologia 2001; 44: 433-6. [CrossRef]
51. Baugh MD, Gavrilovic J, Davies IR, Hughes DA, Sampson MJ. Monocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional study. Cardiovasc Diabetol 2003; 2: 3. [CrossRef]
52. Golledge J, Karan M, Moran CS, Muller J, Clancy P Dear AE, et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interac- tions. Eur Heart J 2008; 29: 665-72. [CrossRef]
53. Iida Y, Xu B, Schultz GM, Chow V, White JJ, Sulaimon S, et al. Efficacy and mechanism of angiotensin II receptor blocker treat- ment in experimental abdominal aortic aneurysms. PLoS One 2012; 7: e49642. [CrossRef]
54. Jones A, Deb R, Torsney E, Howe F, Dunkley M, Gnaneswaran Y, et al. Rosiglitazone reduces the development and rupture of experi- mental aortic aneurysms. Circulation 2009; 119: 3125-32. [CrossRef]
55. Karrowni W, Dughman S, Hajj GP Miller FJ Jr. Statin therapy reduces growth of abdominal aortic aneurysms. J Investig Med 2011; 59: 1239-43.

APA	HUANG Q, LİU J, CHEN M, LI J (2014). Relation of diabetes to coronary artery ectasia: A meta-analysis study. , 322 - 327.
Chicago	HUANG Qiao-Juan,LİU Jun,CHEN Meng-Hua,LI Jian-Jun Relation of diabetes to coronary artery ectasia: A meta-analysis study. (2014): 322 - 327.
MLA	HUANG Qiao-Juan,LİU Jun,CHEN Meng-Hua,LI Jian-Jun Relation of diabetes to coronary artery ectasia: A meta-analysis study. , 2014, ss.322 - 327.
AMA	HUANG Q,LİU J,CHEN M,LI J Relation of diabetes to coronary artery ectasia: A meta-analysis study. . 2014; 322 - 327.
Vancouver	HUANG Q,LİU J,CHEN M,LI J Relation of diabetes to coronary artery ectasia: A meta-analysis study. . 2014; 322 - 327.
IEEE	HUANG Q,LİU J,CHEN M,LI J "Relation of diabetes to coronary artery ectasia: A meta-analysis study." , ss.322 - 327, 2014.
ISNAD	HUANG, Qiao-Juan vd. "Relation of diabetes to coronary artery ectasia: A meta-analysis study". (2014), 322-327.

APA	HUANG Q, LİU J, CHEN M, LI J (2014). Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyoloji Dergisi, 14(4), 322 - 327.
Chicago	HUANG Qiao-Juan,LİU Jun,CHEN Meng-Hua,LI Jian-Jun Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyoloji Dergisi 14, no.4 (2014): 322 - 327.
MLA	HUANG Qiao-Juan,LİU Jun,CHEN Meng-Hua,LI Jian-Jun Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyoloji Dergisi, vol.14, no.4, 2014, ss.322 - 327.
AMA	HUANG Q,LİU J,CHEN M,LI J Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyoloji Dergisi. 2014; 14(4): 322 - 327.
Vancouver	HUANG Q,LİU J,CHEN M,LI J Relation of diabetes to coronary artery ectasia: A meta-analysis study. Anadolu Kardiyoloji Dergisi. 2014; 14(4): 322 - 327.
IEEE	HUANG Q,LİU J,CHEN M,LI J "Relation of diabetes to coronary artery ectasia: A meta-analysis study." Anadolu Kardiyoloji Dergisi, 14, ss.322 - 327, 2014.
ISNAD	HUANG, Qiao-Juan vd. "Relation of diabetes to coronary artery ectasia: A meta-analysis study". Anadolu Kardiyoloji Dergisi 14/4 (2014), 322-327.